¸ÇƲ¼¼Æ÷ ¸²ÇÁÁ¾ ½ÃÀå : ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø - Áø´Üº°, Ä¡·áº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Mantle Cell Lymphoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Diagnosis, By Treatment, By End User, By Region and Competition, 2020-2030F
»óǰÄÚµå : 1728110
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 185 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,197,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,574,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,017,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸ÇƲ¼¼Æ÷ ¸²ÇÁÁ¾ ¼¼°è ½ÃÀåÀº 2024³â 25¾ï 3,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È CAGR 7.80%·Î ¼ºÀåÇÏ¿© 2030³â±îÁö 39¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ÇƲ¼¼Æ÷ ¸²ÇÁÁ¾(MCL)Àº ºñÈ£ÁöŲ¸²ÇÁÁ¾ÀÇ Èñ±ÍÇÏ°í °ø°ÝÀûÀÎ ¾ÆÇüÀ¸·Î, ¸²ÇÁ°è ³» B¸²ÇÁ±¸ÀÇ ºñÁ¤»óÀûÀÎ Áõ½ÄÀ» Ư¡À¸·Î Çϸç, Àüü ¸²ÇÁÁ¾ »ç·Ê¿¡¼­ Â÷ÁöÇÏ´Â ºñÁßÀº ÀûÁö¸¸ ÁøÇàÀÌ ºü¸£°í Ä¡·á ¿É¼ÇÀÌ Á¦ÇÑÀûÀ̱⠶§¹®¿¡ ÀÓ»óÀûÀ¸·Î Áß¿äÇÑ ¹®Á¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ÃÖ±Ù ¸î ³â µ¿¾È, ƯÈ÷ ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϱâ À§ÇÑ Ç¥ÀûÄ¡·á¿Í ¸é¿ªÄ¡·áÀÇ ÃâÇöÀ¸·Î ÀÌ ºÐ¾ß¿¡¼­ Å« ÁøÀüÀÌ ÀÖ¾ú½À´Ï´Ù. È­Çпä¹ýÀ̳ª Áٱ⼼Æ÷ À̽İú °°Àº ±âÁ¸ Ä¡·á¹ýÀº Àå±âÀûÀÎ ¼º°øÀÌ Á¦ÇÑÀûÀ̾ º¸´Ù ƯÀÌÀûÀÌ°í µ¶¼ºÀÌ ÀûÀº Ä¡·á¹ýÀ¸·ÎÀÇ ÀüȯÀÌ ¿ä±¸µÇ°í ÀÖÀ¸¸ç, MCL ¼¼Æ÷ÀÇ »ýÁ¸°ú Áõ½ÄÀ» À¯ÁöÇÏ´Â Áß¿äÇÑ °æ·Î¸¦ ¾ïÁ¦ÇÏ´Â ºê·çÅæ Ƽ·Î½Å Ű³ª¾ÆÁ¦(BTK) ¾ïÁ¦Á¦³ª Æ÷½ºÆ÷À̳ë½ÃŸÀ̵å3 Ű³ª¾ÆÁ¦(PI3 K) ¾ïÁ¦Á¦ÀÇ µµÀÔÀº ȹ±âÀûÀÎ ¹ßÀüÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº Ä¡·á Àü·«À» À籸¼ºÇϰí MCL Ä¡·á ½ÃÀåÀÇ ÀáÀç·ÂÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð : 2024³â 25¾ï 3,000¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð : 2030³â 39¾ï 7,000¸¸ ´Þ·¯
CAGR : 2025-2030³â 7.80%
±Þ¼ºÀå ºÎ¹® Ä¡·á
ÃÖ´ë ½ÃÀå ºÏ¹Ì

ÁÖ¿ä ½ÃÀå ÃËÁø¿äÀÎ

Ç¥Àû Ä¡·áÀÇ ¹ßÀü

ÁÖ¿ä ½ÃÀå °úÁ¦

Áúº´ÀÇ ºÒ±ÕÀϼº

ÁÖ¿ä ½ÃÀå µ¿Çâ

ÅõÀÚ ¹× ÀÚ±Ý Á¶´Þ Áõ°¡

¸ñÂ÷

Á¦1Àå Á¦Ç° °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼¼°èÀÇ ¸ÇƲ¼¼Æ÷ ¸²ÇÁÁ¾ ½ÃÀå Àü¸Á

Á¦5Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¸ÇƲ¼¼Æ÷ ¸²ÇÁÁ¾ ½ÃÀå Àü¸Á

Á¦6Àå À¯·´ÀÇ ¸ÇƲ¼¼Æ÷ ¸²ÇÁÁ¾ ½ÃÀå Àü¸Á

Á¦7Àå ºÏ¹ÌÀÇ ¸ÇƲ¼¼Æ÷ ¸²ÇÁÁ¾ ½ÃÀå Àü¸Á

Á¦8Àå ³²¹ÌÀÇ ¸ÇƲ¼¼Æ÷ ¸²ÇÁÁ¾ ½ÃÀå Àü¸Á

Á¦9Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¸ÇƲ¼¼Æ÷ ¸²ÇÁÁ¾ ½ÃÀå Àü¸Á

Á¦10Àå ½ÃÀå ¿ªÇÐ

Á¦11Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦12Àå ¼¼°èÀÇ ¸ÇƲ¼¼Æ÷ ¸²ÇÁÁ¾ ½ÃÀå : SWOT ºÐ¼®

Á¦13Àå Porter's Five Forces ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

Á¦15Àå Àü·«Àû Á¦¾È

Á¦16Àå Á¶»ç ȸ»ç ¼Ò°³ ¹× ¸éÃ¥»çÇ×

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Mantle Cell Lymphoma Market was valued at USD 2.53 billion in 2024 and is projected to reach USD 3.97 billion by 2030, growing at a CAGR of 7.80% during the forecast period. Mantle cell lymphoma (MCL), a rare and aggressive subtype of non-Hodgkin lymphoma, is characterized by the abnormal proliferation of B lymphocytes within the lymphatic system. Although MCL accounts for a small proportion of overall lymphoma cases, its rapid progression and limited curative treatment options make it a significant clinical concern. Recent years have seen substantial advancements in the field, particularly with the emergence of targeted therapies and immunotherapies aimed at improving patient outcomes. Traditional methods, such as chemotherapy and stem cell transplantation, have shown restricted long-term success, prompting a shift towards more specific and less toxic treatments. Notable breakthroughs include the introduction of Bruton's tyrosine kinase (BTK) inhibitors and phosphoinositide 3-kinase (PI3K) inhibitors, which interfere with critical pathways that sustain MCL cell survival and proliferation. These innovations are reshaping therapeutic strategies and expanding the market potential for MCL treatments.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.53 Billion
Market Size 2030USD 3.97 Billion
CAGR 2025-20307.80%
Fastest Growing SegmentTherapy
Largest MarketNorth America

Key Market Drivers

Advancements in Targeted Therapies

Technological progress in targeted therapies is a major catalyst for growth in the global mantle cell lymphoma market. MCL, known for its resistance to conventional treatments, has seen a significant transformation with the development of targeted approaches like BTK inhibitors, including ibrutinib, which specifically disrupt the BTK signaling protein that promotes tumor cell survival. These therapies have shown marked improvements in progression-free survival and patient quality of life, thereby attracting growing attention from healthcare providers and industry stakeholders. Additionally, PI3K inhibitors offer an alternative for patients not responding to BTK therapies, further diversifying the treatment landscape. The advancement of combination regimens, integrating multiple targeted agents, also holds promise for enhancing therapeutic efficacy and minimizing resistance. These innovations, supported by biomarker research and genetic profiling, are enabling more personalized treatment protocols and reinforcing the expansion of the MCL market.

Key Market Challenges

Heterogeneity of Disease

The complexity and variability of mantle cell lymphoma present a critical challenge to its clinical management and market growth. MCL encompasses a wide spectrum of disease behaviors-from indolent to highly aggressive subtypes-making it difficult to standardize treatment approaches. The diversity in disease progression among patients necessitates personalized therapy plans, which increases the difficulty of creating one-size-fits-all treatment models. Furthermore, the genetic heterogeneity of MCL tumors complicates drug development, as different mutations and molecular subtypes respond variably to treatment. This also hampers clinical trial design, as many studies focus on specific patient segments, limiting the generalizability of results across the broader MCL population.

Key Market Trends

Rising Investments and Funding

Increased investment and funding are playing a pivotal role in propelling the growth of the mantle cell lymphoma market. With the emergence of promising therapies, the MCL segment has attracted substantial attention from pharmaceutical companies, venture capitalists, and institutional investors. This surge in financial backing is accelerating research and development efforts, facilitating the introduction of innovative therapies and expanding access to advanced treatment options. Alongside private investment, public grants and nonprofit initiatives are also bolstering academic research, patient support services, and advocacy efforts. These combined financial inputs are enhancing manufacturing capabilities, supporting awareness campaigns, and strengthening the overall ecosystem for MCL treatment and management.

Key Market Players

Report Scope:

In this report, the Global Mantle Cell Lymphoma Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Mantle Cell Lymphoma Market, By Diagnosis:

Mantle Cell Lymphoma Market, By Treatment:

Mantle Cell Lymphoma Market, By End User:

Mantle Cell Lymphoma Market, By Region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Mantle Cell Lymphoma Market.

Available Customizations:

Global Mantle Cell Lymphoma Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Global Mantle Cell Lymphoma Market Outlook

5. Asia Pacific Mantle Cell Lymphoma Market Outlook

6. Europe Mantle Cell Lymphoma Market Outlook

7. North America Mantle Cell Lymphoma Market Outlook

8. South America Mantle Cell Lymphoma Market Outlook

9. Middle East and Africa Mantle Cell Lymphoma Market Outlook

10. Market Dynamics

11. Market Trends & Developments

12. Global Mantle Cell Lymphoma Market: SWOT Analysis

13. Porter's Five Forces Analysis

14. Competitive Landscape

15. Strategic Recommendations

16. About Us & Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â